-
SML3420-25MG
KY-226 (C15-1720-811)
Price: $534.91List Price: $594.34Biochem/physiol Actions KY-226 is an orally bioavailable, potent and selective allosteric inhibitor of protein tyrosine phosphatase 1B (PTP1B) that does not function as a PPARg agonist. KY-226 exhibits anti-diabetic, anti-obesity effects by -
SML0603-5MG
LIXIVAPTAN (C15-1725-003)
Price: $230.93List Price: $256.58Biochem/physiol Actions Arginine vasopressin (AVP) plays an important part in circulatory and water homoeostasis and is important in renal hemodynamic alterations, water retention, and cardiac remodeling in congestive heart failure (CHF). -
SML0603-25MG
LIXIVAPTAN (C15-1725-004)
Price: $718.50List Price: $798.34Biochem/physiol Actions Arginine vasopressin (AVP) plays an important part in circulatory and water homoeostasis and is important in renal hemodynamic alterations, water retention, and cardiac remodeling in congestive heart failure (CHF). -
SML3569-5MG
M4K2234 (C15-1720-548)
Price: $365.89List Price: $406.54Biochem/physiol Actions M4K2234 is a potent and selective TGF-β: type I receptors ALK1/ACVRL1 &: ALK2/ACVR1 inhibitor (IC50 = 7/14 nM, [ATP] = 10 mM) that inhibits TNIK and ALK6/BMPR1B only at higher concentrations (IC50 = 41 &: 88 nM, -
Ab183134-100μg
MEDI-3617 (anti-ANGPT2) (C09-1944-056)
Price: $190.21List Price: $211.35MEDI-3617 (anti-ANGPT2) is a human monoclonal antibody directed against the angiogenic cytokines angiopoietin-2 (Angpt2). MEDI-3617 (anti-ANGPT2) in combination with tremelimumab is used to treat advanced melanoma. -
Ab183134-10mg
MEDI-3617 (anti-ANGPT2) (C09-1944-057)
Price: $2,618.06List Price: $2,908.96MEDI-3617 (anti-ANGPT2) is a human monoclonal antibody directed against the angiogenic cytokines angiopoietin-2 (Angpt2). MEDI-3617 (anti-ANGPT2) in combination with tremelimumab is used to treat advanced melanoma. -
Ab183134-1mg
MEDI-3617 (anti-ANGPT2) (C09-1944-058)
Price: $632.31List Price: $702.57MEDI-3617 (anti-ANGPT2) is a human monoclonal antibody directed against the angiogenic cytokines angiopoietin-2 (Angpt2). MEDI-3617 (anti-ANGPT2) in combination with tremelimumab is used to treat advanced melanoma. -
Ab183134-5mg
MEDI-3617 (anti-ANGPT2) (C09-1944-059)
Price: $1,702.58List Price: $1,891.76MEDI-3617 (anti-ANGPT2) is a human monoclonal antibody directed against the angiogenic cytokines angiopoietin-2 (Angpt2). MEDI-3617 (anti-ANGPT2) in combination with tremelimumab is used to treat advanced melanoma. -
15187-1
ML-233-1 mg
Price: $148.23List Price: $164.70A novel apelin receptor agonist (EC<sub>50</sub> = 3.7 &muM) that is >21-fold selective over the closely related angiotensin I receptor (EC<sub>50</sub> = >79 &muM). -
15187-10
ML-233-10 mg
Price: $487.05List Price: $541.17A novel apelin receptor agonist (EC<sub>50</sub> = 3.7 &muM) that is >21-fold selective over the closely related angiotensin I receptor (EC<sub>50</sub> = >79 &muM). -
15187-25
ML-233-25 mg
Price: $888.83List Price: $987.59A novel apelin receptor agonist (EC<sub>50</sub> = 3.7 &muM) that is >21-fold selective over the closely related angiotensin I receptor (EC<sub>50</sub> = >79 &muM). -
15187-5
ML-233-5 mg
Price: $351.26List Price: $390.29A novel apelin receptor agonist (EC<sub>50</sub> = 3.7 &muM) that is >21-fold selective over the closely related angiotensin I receptor (EC<sub>50</sub> = >79 &muM).